| |
| Agreement between Clausen and the Special Techniques Laboratory |
| Thursday, March 25, 2010 |
| Laboratorios Clausen S.A. would like to inform the healthcare professionals that we have reached an agreement with our product Kimatinib (Imatinib Mesylate), at the Special Techniques Laboratory of the "Asociación Española Primera de Socorros Mutuos in Montevideo- Uruguay" |
|